(Reuters) – Quest Diagnostics on Thursday received emergency use authorization from the U.S. Food and Drug Administration for its self-collection COVID-19 test kit.
The test allows people to swab the front part of the nostril at home or in a healthcare setting when deemed necessary.
(Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren Daniel)
